Cabolong 60mg | Cabozantinib Tablets | for Kidney &  Liver Cancer

Cabolong 60mg | Cabozantinib Tablets | for Kidney & Liver Cancer

  • Brand: MSN Laboratories
  • Model: Cabolong 60mg
  • SKU: CBZb60
  • Active Ingredient: Cabozantinib
  • Treatment: Kidney Cancer & Liver Cancer
  • Availability: In Stock

Available Options

  • $150.00 - $1,499.00

Introduction of Cabolong 60mg


Cabolong 60 mg is a prescription cancer medication that contains Cabozantinib, a potent tyrosine kinase inhibitor (TKI). It is used to treat various forms of advanced or metastatic cancer, including:

  • Renal Cell Carcinoma (RCC) – advanced kidney cancer

  • Hepatocellular Carcinoma (HCC) – liver cancer in patients previously treated with sorafenib

Cabozantinib works by blocking multiple tyrosine kinases involved in cancer cell growth, angiogenesis (blood supply formation), and metastasis. It targets pathways such as MET, VEGFR, AXL, and others, making it a broad-spectrum agent in targeted cancer therapy.

Key Benefits

  • Approved treatment for advanced kidney, liver, and thyroid cancers

  • Inhibits tumor growth, angiogenesis, and metastasis

  • Improves progression-free and overall survival

  • Convenient oral once-daily dosing

  • Suitable for patients who have progressed on prior systemic therapies

Possible Side Effects

Common side effects include:

  • Fatigue

  • Diarrhea or constipation

  • Decreased appetite

  • Nausea or vomiting

  • High blood pressure

  • Mouth sores

  • Skin rash

  • Weight loss

Precautions & Warnings

  • Not safe during pregnancy or breastfeeding – may harm unborn baby

  • Use cautiously in patients with liver or kidney impairment

  • Avoid use with grapefruit juice, which can increase drug levels

  • Not recommended for patients with recent surgery due to wound healing risks

  • Inform your doctor about all medications, supplements, or herbal remedies being taken

Storage Instructions

  • Store at 20–25°C (68–77°F)

  • Keep in original packaging, away from light, heat, and moisture

  • Keep out of reach of children and pets

Cabolong 60 mg (Cabozantinib) is a highly effective targeted therapy for the treatment of several advanced-stage cancers, including renal cell carcinoma, hepatocellular carcinoma, and medullary thyroid cancer. By blocking multiple tumor-promoting pathways, it helps to slow disease progression, extend survival, and improve clinical outcomes. When taken under proper medical supervision, Cabolong plays a vital role in modern cancer care.


There are no reviews for this product.

Write a review

Note: HTML is not translated!
    Bad           Good